Related Experiment Video
Updated: Sep 28, 2026
Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
Idiopathic myelofibrosis with prominent postsplenectomy erythroblastosis terminating in acute myeloid transformation
11st Department of Internal Medicine, County Hospital, Zala, Hungary. zmk-l-bel@zalaszam.hu
Abstract:
Idiopathic myelofibrosis is a myeloproliferative disease with poor prognosis and without sufficient therapy. Acute leukemic transformation occurs in 15% of patients. The authors report the case of a 63 year old myelofibrotic patient treated with splenectomy. During the clinical course they observed unusually prominent and persistent erythroblastosis in the peripherial blood. After a two years long, relatively stable period the disease terminated in acute myeloid leukemia.
Insights
Idiopathic myelofibrosis, a serious blood cancer, can transform into acute myeloid leukemia. This case highlights persistent erythroblastosis as a notable clinical observation during disease progression.
Area of Science:
- Hematology
- Oncology
Background:
- Idiopathic myelofibrosis is a myeloproliferative neoplasm with a poor prognosis.
- Acute leukemic transformation occurs in approximately 15% of patients with idiopathic myelofibrosis.
- Current therapeutic options for idiopathic myelofibrosis are limited.
Purpose of the Study:
- To report a case of idiopathic myelofibrosis with unusual clinical findings.
- To describe the progression of the disease, including acute myeloid leukemia transformation.
Main Methods:
- Case report of a 63-year-old male patient with idiopathic myelofibrosis.
- Treatment with splenectomy was administered.
- Clinical course and peripheral blood findings were monitored.
Main Results:
- The patient exhibited unusually prominent and persistent erythroblastosis in peripheral blood.
- Following a two-year stable period after splenectomy, the disease progressed.
- The patient ultimately transformed into acute myeloid leukemia.
Conclusions:
- Persistent erythroblastosis may be a significant clinical observation in idiopathic myelofibrosis.
- This case illustrates a potential indicator of disease progression towards acute myeloid leukemia transformation.
More Related Videos
06:33Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia
Published on: November 10, 2023
11:59Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
